Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 39 for APIXABAN
  1. Apixaban is used to: prevent strokes or blood clots in people who have atrial fibrillation (a condition ... lung) in certain situations. treat DVT and PE Apixaban is in a class of medications called factor ...
  2. Bruising and Bleeding (Merck & Co., Inc.)  
    Bleeding Disorders/Start Here ... Bleeding Disorders ... Merck & Co., Inc. ... Bruising and Bleeding - Learn about the causes, symptoms, diagnosis & treatment from the Merck ...
  3. ... disorders. Other examples of biologic medicines include: Adalimumab. Apixaban. Nivolumab. Pembrolizumab. Rituximab. Why do I need TDM? ...
  4. ... The medicines warfarin (Coumadin, Jantoven), rivaroxaban (Xarelto), and apixaban (Eliquis) are examples of blood thinners. If you' ...
  5. ... warfarin or novel oral anticoagulants (NOACs, such as apixaban, rivaroxaban, and others) Calcium channel blockers, diuretics (water ...
  6. ... prasugrel (Effient), ticagrelor (Brilinta), warfarin (Coumadin or Jantoven), apixaban (Eliquis), rivaroxaban (Xarelto), edoxaban (Savaysa), dabigatran (Pradaxa), can ...
  7. ... blood thinner, such as ticagrelor (Brilinta), prasugrel (Effient), apixaban (Eliquis), dabigatran (Xarelto), and rivaroxaban (Pradaxa), edoxaban (Savaysa). ...
  8. ... Clopidogrel (Plavix), warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis) You may also be told to stop ...
  9. ... such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), clopidogrel (Plavix) Vitamin E Ask your surgeon ...
  10. ... thinners are called direct oral anticoagulants (DOAC), including: Apixaban (Eliquis) Dabigatran (Pradaxa) Edoxaban (Savaysa) Rivaroxaban (Xarelto) These ...
previous · 1 · 2 · 3 · 4 · next